September 24, 2016 5:45 PM ET

Healthcare Providers and Services

Company Overview of Counsyl, Inc.

Company Overview

Counsyl, Inc. provides genetic testing and DNA analysis services. The company offers Family Prep Screen service that detects various conditions that can be passed from parent to child; carrier screening services; Informed Pregnancy Screen service, which provides early insight into baby's development by screening for chromosome conditions, such as down and turner syndrome; and Inherited Cancer Screen service that analyzes DNA for twenty genes associated with an increased risk of developing cancer. It also provides support services; and online services that allow users to track, monitor, and follow up with their patients. In addition, the company offers Counsyl Complete, a platform for deliver...

180 Kimball Way

South San Francisco, CA 94080

United States

Founded in 2007





Key Executives for Counsyl, Inc.

Co-Founder and Chief Executive Officer
Co-Founder and Vice President of Engineering
Co-Founder and Chief Science Officer
Co-Founder and Community Advisor
Chief Financial Officer
Age: 58
Compensation as of Fiscal Year 2016.

Counsyl, Inc. Key Developments

Counsyl, Inc. Presents at 36th Annual Canaccord Genuity Growth Conference 2016, Aug-10-2016 11:30 AM

Counsyl, Inc. Presents at 36th Annual Canaccord Genuity Growth Conference 2016, Aug-10-2016 11:30 AM. Venue: InterContinental Hotel, Boston, Massachusetts, United States.

Counsyl, Inc. Presents at UBS Genomics 2.0 Summit, Aug-11-2016 07:30 AM

Counsyl, Inc. Presents at UBS Genomics 2.0 Summit, Aug-11-2016 07:30 AM. Venue: St. Regis Deer Valley, Park City, Utah, United States. Speakers: Ramji Srinivasan, Co-Founder and Chief Executive Officer, Ted Snelgrove, Chief Business Officer.

Counsyl Announces Management Changes

Counsyl announced two strategic appointments to its executive leadership team: Joel Jung, Chief Financial Officer and Peter Soparkar, General Counsel. Joel Jung joins Counsyl with nearly 20 years of experience as an executive in the life sciences industry. Most recently, Joel was the Chief Financial Officer of BioNano Genomics. Peter Soparkar joins Counsyl from Jazz Pharmaceuticals, where he led the legal team’s operations support and delivered on numerous debt and equity financings and four landmark transactions, including the launched tender-offer of Celator, the acquisitions of Italy-based Gentium, UK based EUSA Pharma, and the acquisition of and inversion into Ireland based Azur Pharma.

Similar Private Companies By Industry

Company Name Region
@ Home Medical, Inc. United States
@home approach, llc United States
@Home Care United States
1011 E. Pecan Grove Road, LLC United States
1125 Sir Francis Drake Boulevard Operating Company, Llc United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Counsyl, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at